Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neuroendocrine Tumors 1 Neoplasms 1 Breast Neoplasms 1

Interventions

pembrolizumab 90 Blood Specimen Collection 44 Cyclophosphamide 37 Nivolumab 35 Bevacizumab 35 Standard of Care 32 Carboplatin 30 Surveys and Questionnaires 29 Paclitaxel 28 atezolizumab 24 Pemetrexed 24 Gemcitabine 24 Exercise 24 Fluorouracil 23 Cisplatin 23 Leucovorin 21 Dexamethasone 20 Radiotherapy 19 Oxaliplatin 19 Docetaxel 19 Rituximab 16 Irinotecan 16 Cetuximab 16 dostarlimab 15 Ipilimumab 15 Doxorubicin 15 Biopsy 15 130-nm albumin-bound paclitaxel 15 Drug Therapy 14 fludarabine 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × 68Ga-FAPI × 1 year × Clear all

NCT05034146 2025-06-05

68Ga-FAPI PET/CT in Malignant Tumors

Zhongnan Hospital

Phase NA Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡